One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who ...

Augmentin XR's approval under CNPV addresses antibiotic shortages and strengthens U.S. manufacturing, enhancing national security. The CNPV program expedites drug reviews, reducing the timeline from ...

The FDA has approved Augmentin XR, an oral antibacterial, under its Commissioner’s National Priority Voucher pilot program, marking the first approval granted through the expedited review pathway. The ...

Less than two weeks into his new role as Auburn's head football coach, Alex Golesh has a tremendous task ahead of him. AUBURN, Ala.-- A little over ten days into his tenure on the plains, new Auburn ...

The U.S. House of Representatives has given a unanimous thumbs-up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having secured ultrafast drug reviews, questions and criticisms about the initiative ...

Michigan’s new LEADS pilot aims to help employers reduce stress, burnout and communication-related risks by integrating mental health into core occupational health and safety practices. A new Michigan ...

On Thursday, the U.S. Food and Drug Administration (FDA) announced six additional awardees under the Commissioner's National Priority Voucher (CNPV) pilot program. The second cohort brings the total ...

Editor's note: This article has been updated to provide clarity on a head-to-head study Eli Lilly conducted on its candidate, orforglipron. A pill version under development of Novo Nordisk's (NVO) GLP ...

Priority Health is continuing its mission of supporting student mental health with the placement of three highly trained working facility dogs at schools in southeast Michigan – the first dogs to ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...